Wuhan Union Hospital, China: all 229 studies

Page 1 of 3. Open to participants first (103), then studies with results posted, then the rest; newest registration first within each.

• Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies）Not yet recruitingNCT07007767Phase 2
• Clinical Application of PET Imaging Targeting Nectin-4 in Malignant TumorsNot yet recruitingNCT06994078Not applicable
• SHR-A1811 and THPy in First or Second Line for HER2 Positive Advanced Breast Cancer Brain MetastasesNot yet recruitingNCT06975475Phase 2
• A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain MetastasesNot yet recruitingNCT06975462Phase 2
• An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus ErythematosusNot yet recruitingNCT06945068Phase 1
• Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)RecruitingNCT06922851Not applicable
• AI-guided TIPS ProcedureNot yet recruitingNCT06837974Not applicable
• AI-based Low Dose CBCT Reconstruction for Clinical ApplicationNot yet recruitingNCT06831617Not applicable
• Application of 18F-CP6A PET Imaging in SynucleinopathiesNot yet recruitingNCT06827821Early Phase 1
• Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal CancerRecruitingNCT06802666Phase 2
• Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational StudyRecruitingNCT06791889
• Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid FailureNot yet recruitingNCT06790888Not applicable
• Effects of Low Tidal Volume and Airway Pressure Release Ventilation on Lung Tissue Mechanics in ARDS Patients Under Mechanical Ventilation: A Prospective Randomized Crossover StudyRecruitingNCT06790875Not applicable
• The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step TrialRecruitingNCT06785571Phase 2/3
• (Withdrawal) AI-Based Low-Dose 3D-DSA ReconstructionNot yet recruitingNCT06769867Not applicable
• Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated CardiomyopathyRecruitingNCT06741995
• CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic TumorsRecruitingNCT06735495Phase 1/2
• RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell MalignanciesRecruitingNCT06732492Phase 1
• CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic TumorsRecruitingNCT06720324Phase 1/2
• A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal CancerRecruitingNCT06717880Phase 1
• An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's LymphomaRecruitingNCT06693973Early Phase 1
• Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITPRecruitingNCT06686927Phase 2
• A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal MetastasisRecruitingNCT06685887Phase 2
• Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and TreatmentRecruitingNCT06653478
• The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous CarcinomaEnrolling by invitationNCT06647836
• Screening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age PatientEnrolling by invitationNCT06591442
• Endovascular Treatment for Stroke Post 1 Day （24 Hours）Not yet recruitingNCT06580730Not applicable
• Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARCRecruitingNCT06542588Phase 2
• Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）RecruitingNCT06537037
• AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06537011Phase 2
• Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）RecruitingNCT06536998
• Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMMRecruitingNCT06503107Phase 1/2
• CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsRecruitingNCT06503094Phase 1/2
• Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）RecruitingNCT06500312
• Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic CancerRecruitingNCT06491472Phase 2
• The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System TumorsRecruitingNCT06490211
• Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal MetastasisEnrolling by invitationNCT06487715Phase 2
• Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric CancerRecruitingNCT06487429Phase 2
• Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance ImagingNot yet recruitingNCT06475066Not applicable
• Phase I Clinical Trial of UC-MSCs in the Treatment of Knee OsteoarthritisRecruitingNCT06463847Phase 1
• Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular CarcinomaRecruitingNCT06383520Early Phase 1
• Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast CancerRecruitingNCT06367088Phase 2
• Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic CancerNot yet recruitingNCT06361030Phase 2
• Study of SYS6020 in BCMA-positive Multiple MyelomaNot yet recruitingNCT06359509Early Phase 1
• Clinical Study of Desuzumab in the Treatment of Knee OsteoarthritisRecruitingNCT06357741
• CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus ErythematosusRecruitingNCT06349343Phase 1
• Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal CancerRecruitingNCT06347198Early Phase 1
• Diagnosis of Leptomeningeal Metastasis and the Monitoring of Intrathecal Chemotherapy Efficacy in NSCLCNot yet recruitingNCT06346977
• Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant ImmunochemotherapyNot yet recruitingNCT06285058
• A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M ScoreNot yet recruitingNCT06279338Not applicable
• Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric JunctionRecruitingNCT06250894Phase 2
• UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid LeukemiaRecruitingNCT06245746Phase 1
• HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular CarcinomaRecruitingNCT06244225Phase 2
• Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCTRecruitingNCT06241274Not applicable
• Short-course Radiotherapy Followed by Fruquintinib Plus Adebrelimab and CAPOX in the Full Course Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Multicenter, Single-arm, Open-label StudyRecruitingNCT06234007Phase 2
• The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical TrialRecruitingNCT06228794
• Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related OutcomesRecruitingNCT06154707Phase 3
• Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple MyelomaRecruitingNCT06140966Phase 2
• Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract CancerNot yet recruitingNCT06134193Phase 2
• Tucidinostat Plus Apatinib for Advanced OsteosarcomaNot yet recruitingNCT06125171Phase 2
• A Clinical Study of CD19 CAR-T in Active Systemic Lupus ErythematosusRecruitingNCT06106906Phase 1/2
• Fruquintinib in the Cross-line Treatment of Refractory mCRCRecruitingNCT06099314
• Preoperative Assessment of Pathological Nipple Discharge With Delayed Ductal Imaging of Contrast-enhanced MammographyRecruitingNCT06033573Not applicable
• Study on the Protective Effect of Gastrodin on Myocardial Injury in Patients Undergoing Cardiac SurgeryRecruitingNCT06012968
• Study on the Effect of Target-controlled Infusion for General Anesthesia in Cardiac SurgeryRecruitingNCT06012955
• A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast CancerRecruitingNCT06000917Phase 2
• 68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With ImmunotherapyRecruitingNCT05999227Not applicable
• A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of TherapyRecruitingNCT05998928Phase 2
• A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant PatientsRecruitingNCT05994274
• Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCCNot yet recruitingNCT05993858Phase 2
• Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft TissueRecruitingNCT05963035Not applicable
• Disitamab Vedotin Combined With Radiotherapy for Bladder PreservationNot yet recruitingNCT05912205Phase 2
• Molecular Study and Precision Medicine for Colorectal CancerNot yet recruitingNCT05883683
• Robot-assisted Function-sparing Cystectomy Followed by Modified Orthotopic Ileal NeobladderRecruitingNCT05881642Not applicable
• Effects of Pioglitazone in Calcific Aortic Valve DiseaseNot yet recruitingNCT05875675Phase 2
• Effect of Inhaled Nitric Oxide on Pulmonary Ventilation/Perfusion Ratio Assessed by EIT in Patients With ARDSRecruitingNCT05873647
• Folic Acid Supplementation in Calcific Aortic Valve DiseaseNot yet recruitingNCT05861648Phase 2
• The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 ExpressionRecruitingNCT05861635Phase 4
• Blood Cell RNA-Based Cancer DetectionRecruitingNCT05839834
• Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung AdenocarcinomaRecruitingNCT05830812
• Cadonilimab (AK104) in the Treatment of Nasopharyngeal CarcinomaRecruitingNCT05790200Phase 2
• High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention ProgramRecruitingNCT05782881Not applicable
• Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MVNot yet recruitingNCT05768230Phase 2/3
• SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRCNot yet recruitingNCT05747716Phase 2
• Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic SyndromeEnrolling by invitationNCT05674539Phase 3
• High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized StudyRecruitingNCT05585151Phase 4
• Long-term Sedation With Remimazolam Besylate in Critically Ill PatientsRecruitingNCT05555667Phase 3
• Comparison Among Three Different Video Scope Guided Nasotracheal Intubation.Not yet recruitingNCT05534451Not applicable
• Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid TumorsNot yet recruitingNCT05527821Phase 2
• Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer PatientsNot yet recruitingNCT05498766Phase 4
• Alterations of Gut Microbiota and Serum Biochemical Markers in DILI PatientsRecruitingNCT05465642
• Alterations of Gut Microbiota and Metabolites in ALD PatientsRecruitingNCT05448144
• Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid LeukemiaRecruitingNCT05445011Phase 1
• Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and TreatmentRecruitingNCT05426135
• Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced GastricNot yet recruitingNCT05387681Phase 2
• An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AANot yet recruitingNCT05333861
• Treatment of Periodontal Disease in Patients With Alzheimer's DiseaseNot yet recruitingNCT05183321Not applicable
• Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell LymphomaRecruitingNCT05020392Phase 3
• Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal ChemotherapyNot yet recruitingNCT04845490Phase 2
• Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal ChemotherapyRecruitingNCT04808466Phase 2

← Wuhan Union Hospital, China overview and focus areas